BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: El-Chennawi FA, Auf FA, Metwally SS, Mosaad YM, Shaaban AA, El-Baz MA, Tawhid ZE, Lotfy ZF. Vascular endothelial growth factor, p53, and the H-ras oncogene in Egyptian patients with bladder cancer. World J Gastrointest Oncol 2009; 1(1): 62-68 [PMID: 21160776 DOI: 10.4251/wjgo.v1.i1.62]
URL: https://www.wjgnet.com/1948-5204/full/v1/i1/62.htm
Number Citing Articles
1
Daye Cheng, Bin Liang, Yunhui Li. Clinical value of vascular endothelial growth factor and endostatin in urine for diagnosis of bladder cancerTumori Journal 2012; 98(6): 762 doi: 10.1177/030089161209800614
2
Yuxuan Song, Yongjiao Yang, Li Liu, Xiaoqiang Liu. Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjectsGene 2019; 698: 186 doi: 10.1016/j.gene.2019.02.070
3
Jun-Xing Chen, Nan Deng, Xu Chen, Ling-Wu Chen, Shao-Peng Qiu, Xiao-Fei Li, Jia-Ping Li. A Novel Molecular Grading Model: Combination of Ki67 and VEGF in Predicting Tumor Recurrence and Progression in Non-invasive Urothelial Bladder CancerAsian Pacific Journal of Cancer Prevention 2012; 13(5): 2229 doi: 10.7314/APJCP.2012.13.5.2229
4
Saber A. Sakr, Hoda A. Mahran, Ahmed M. Fahmy, Meirhan A. El-Kholy, Mahmoud Meawad. Expression of c-erb-B2 gene in bladder cancer of Egyptian patients and its correlation with p53 and bcl-2Biomedicine & Pharmacotherapy 2015; 76: 73 doi: 10.1016/j.biopha.2015.10.021